局部晚期食管癌三联治疗患者中SUR的预后价值
本研究纳入76例新诊断食管癌患者,在放化疗前及新辅助放化疗最后一周行18F-FDG-PET/CT,评估基线PET参数及新辅助放化疗结束时的预后价值。多因素分析显示再分期MTV和再分期SUR与所有终点显著相关,再分期SUR效应量最大。作者认为SUR较SUV能改善示踪剂摄取的预后价值,再分期参数预后价值高于基线PET,尚需进一步研究证实。
要点
- 再分期MTV和再分期SUR在多因素分析中与所有终点显著相关。
- 再分期SUR在所有终点中效应量最大,再分期参数预后价值高于基线PET。
- 作者认为SUR较SUV能改善示踪剂摄取的预后价值,尚需进一步研究证实。
核心结论
- PET在标准临床参数之外为该患者队列提供OS、LRC和FFDM的独立预后信息。
- 作者认为以SUR而非SUV表征示踪剂摄取可改善预后价值。
- 再分期参数较基线PET显示更高的预后价值,此时仍可进行治疗方案调整。
- 需进一步研究证实这些产生假设的结果。
研究设计与样本
- 探索性研究,76例连续新诊断食管癌患者,年龄(60±10)岁,男性71例。
- 在新辅助放化疗前及最后一周行18F-FDG-PET/CT。
- 原发肿瘤MTV采用自适应阈值法勾画,血SUV通过低剂量CT手动勾画主动脉确定,SUR为经扫描时间校正的肿瘤SUVmax与平均血SUV比值。
- 采用单变量Cox回归和Kaplan-Meier分析LRC、FFDM和OS,并用多变量Cox回归分析PET参数与标准临床因素的独立性。
主要发现
- 多因素分析中,再分期MTV和再分期SUR与所有终点显著相关。
- 再分期TLG对LCR和FFDM有预后价值。
- 所有终点中再分期SUR效应量最大。
- 多因素分析中仅组织学对OS和FFDM、年龄对LRC保持显著。
局限性
- 原文为探索性研究,结果属产生假设性质。
- 需进一步研究证实这些结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The prognosis of patients with esophageal carcinoma remains dismal despite ongoing efforts to improve treatment options. For locally advanced tumors, several randomized trials have shown the benefit of neoadjuvant chemoradiation followed by surgery compared to surgery alone. The aim of this exploratory study was to evaluate the prognostic value of different baseline positron emission tomography (PET) parameters and their potentially additional prognostic impact at the end of neoadjuvant radiochemotherapy. Furthermore, the standard uptake ratio (SUR) as a new parameter for quantification of tumor metabolism was compared to the conventional PET parameters metabolic active volume (MTV), total lesion glycolysis (TLG), and standardized uptake value (SUV) taking into account known basic parameters. Methods:18F-FDG-PET/CT was performed in 76 consecutive patients ((60±10) years, 71 males) with newly diagnosed esophageal cancer before and during the last week of neoadjuvant radiochemotherapy. MTV of the primary tumor was delineated with an adaptive threshold method. The blood SUV was determined by manually delineating the aorta in the low dose CT. SUR values were computed as scan time corrected ratio of tumor SUVmax and mean blood SUV. Univariate Cox regression and Kaplan-Meier analysis with respect to locoregional control (LRC), freedom from distant metastases (FFDM), and overall survival (OS) was performed. Additionally, independence of PET parameters from standard clinical factors was analyzed with multivariate Cox regression. Results: In multivariate analysis two parameters showed a significant correlation with all endpoints: restaging MTV and restaging SUR. Furthermore, restaging TLG was prognostic for LCR and FFDM. For all endpoints the largest effect size was found for restaging SUR. The only basic factors remaining significant in multivariate analyses were histology for OS and FFDM and age for LRC. Conclusion: PET provides independent prognostic information for OS, LRC, and FFDM in addition to standard clinical parameters in this patient cohort. Our results suggest that the prognostic value of tracer uptake can be improved when characterized by SUR rather than by SUV. Overall, our investigation revealed a higher prognostic value of restaging parameters compared to baseline PET; therapy-adjustments would still be possible at this point of time. Further investigations are required to confirm these hypothesis-generating results.
引用
- Bütof R, Hofheinz F, Zöphel K, et al. Prognostic value of SUR in patients with trimodality treatment of locally advanced esophageal carcinoma. J Nucl Med. 2018. PMID: 30166358. doi:10.2967/jnumed.117.207670
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。